What is gestational trophoblastic disease?

Gestational trophoblastic disease (GTD) is the name for a group of rare conditions that can develop in the uterus( womb). Although GTD occurs in the uterus, it doesn’t start in cells that make up the uterus. Instead, it starts in the trophoblast.

The trophoblast develops after a sperm and egg join. The fertilized egg divides and grows to become a blastocyst. The blastocyst contains an inner mass of cells (called the embryoblast), which normally develops into an embryo and then a fetus. The trophoblast surrounds the embryoblast and connects it to the wall of the uterus. The trophoblast also forms part of the placenta, which is an organ that develops during pregnancy to provide nutrients and oxygen to a fetus as it grows.

Diagram of a blastocyst
Diagram of a blastocyst

In GTD, the cells that make up the trophoblast don’t develop normally. Instead, they grow out of control and form a tumour.

GTD usually develops just after a sperm and egg join. But it can also occur if trophoblast tissue is still in the uterus after:

  • a miscarriage or abortion

  • a tubal, or ectopic, pregnancy (a pregnancy that happens outside of your uterus)

  • a normal pregnancy

The most common type of GTD is a non-cancerous (benign) tumour called a hydatidiform mole. Doctors may call the presence of a hydatidiform mole a molar pregnancy.

In rare cases, trophoblast cells can develop into a cancerous (malignant) tumour. A non-cancerous hydatidiform mole can also develop into cancer. Cancerous GTD is also called gestational trophoblastic neoplasia (GTN).

Expert review and references

  • National Cancer Institute. Gestational Trophoblastic Disease Treatment (PDQ®)–Patient Version. National Institutes of Health; https://www.cancer.gov/. February 20, 2024.
  • Ross S. Berkowitz, Kevin M. Elias, and Neil S. Horowitz DeVita, Jr Vincent T; Rosenberg, Steven A; Lawrence, Theodore S.. Gestational Trophoblastic Neoplasia. DeVita VT Jr, Lawrence TS, Rosenberg SA. DeVita, Hellman, and Rosenberg's Cancer: Principles & Practice of Oncology. 10th ed. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2015: 75: 1069-1074.
  • Cancer Research UK. What is gestational trophoblastic disease?. https://www.cancerresearchuk.org/. February 20, 2024.
  • American Society of Clinical Oncology (ASCO). Cancer.net: Gestational Trophoblastic Disease: Introduction. February 20, 2024.
  • Guideline Resource Unit (GURU). Gestational Trophoblastic Neoplasia. Edmonton: Alberta Health Services; 2021: Clinical Practice Guideline GYNE-008 – Version 2. https://www.albertahealthservices.ca/info/cancerguidelines.aspx.
  • Ross S. Berkowitz Neil S. Horowitz Donald P. Goldstein Berek, Jonathan; Hacker, Neville F.. Gestational Trophoblastic Disease. Berek JS, Hacker NF (eds.). Berek and Hacker's Gynecologic Oncology. 7th ed. Philadelphia: Wolters Kluwer; 2021: p 562-580.
  • Gestational Trophoblastic Neoplasia. Provincial Health Services Authority. Gestational Trophoblastic Neoplasia. Vancouver, BC: 2021. https://www.bccancer.bc.ca/. February 20, 2024.

Cancerous gestational trophoblastic disease

Cancerous gestational trophoblastic disease (GTD) may also be called gestational trophoblastic neoplasia (GTN). The types of cancerous GTD are invasive mole, gestational choriocarcinoma, placental site trophoblastic tumour (PSTT) and epithelioid trophoblastic tumour (ETT).

Non-cancerous gestational trophoblastic disease

Hydatidiform mole is the most common type of non-cancerous gestational trophoblastic disease (GTD). Atypical placental site nodules and exaggerated placental site reactions are very rare.

Your trusted source for accurate cancer information

With just $5 from readers like you, we can continue to provide the highest quality cancer information for over 100 types of cancer.

We’re here to ensure easy access to accurate cancer information for you and the millions of people who visit this website every year. But we can’t do it alone.

If everyone reading this gave just $5, we could achieve our goal this month to fund reliable cancer information, compassionate support services and the most promising research. Please give today because every contribution counts. Thank you.

Medical disclaimer

The information that the Canadian Cancer Society provides does not replace your relationship with your doctor. The information is for your general use, so be sure to talk to a qualified healthcare professional before making medical decisions or if you have questions about your health.

We do our best to make sure that the information we provide is accurate and reliable but cannot guarantee that it is error-free or complete.

The Canadian Cancer Society is not responsible for the quality of the information or services provided by other organizations and mentioned on cancer.ca, nor do we endorse any service, product, treatment or therapy.


1-888-939-3333 | cancer.ca | © 2025 Canadian Cancer Society